HIV Clinical Trial
Official title:
Effectiveness of Clinician Client Centered Counseling on Knowledge, Attitudes and Sexual Behaviors of Antiretroviral Therapy Patients in Yola, Nigeria
The purpose of this study was to determine the effectiveness of a clinician client centered counseling on knowledge on HIV transmission and prevention, attitudes towards HIV/AIDS, and sexual behaviors of adult HIV patients enrolled in care in Yola, Nigeria.
This study was a 3 arm randomized single blind clinical trial involving 386 randomly
selected and allocated adult HIV patients who were enrolled into Antiretroviral Therapy
(ART) care at all 4 comprehensive ART sites in Yola. These comprehensive sites were the;
Federal Medical Center (FMC) Yola, State Specialist Hospital Yola (SSHY), St Francis
Hospital Jambutu and Adamawa Hospital. The trail took place from January to September 2014.
A Clinician Client Centered training module was developed based on the Information Behavior
and Motivation (IBM) Model. 9 Clinicians involved in ART care were trained with this module
to deliver a 10 to 15 minutes clinic based intervention (Clinician Client Centered (CCC)
counseling). Intervention group 1 received 2 counseling sessions; at baseline then at 2
months. Intervention group 2 received 1 counseling session at baseline only and the control
group received routine care. An interviewer administered validated and reliable structured
questionnaire was used for data collection. The questionnaire consisted of 5 sections;
Section 1 consisted of a code number and socio-demographic variables. Section 2 consisted of
questions on the knowledge of HIV transmission and prevention. This section has a total of
17 statements and answers that had the options of 'yes', 'no' and 'don't know'. Section 3
consisted of 5 statements to address patient's attitude towards HIV/AIDS. Answer options to
these questions were from a 5 point Likert scale ranging from strongly agree, agree, don't
know, disagree and strongly disagree. Total score possible for attitude range from 5 to 25.
On the basis of summated scores respondents were divided into high or low attitude using the
50 percentile as cut off. Section 4; addressed sexual behavior patterns (condom use and
number of sexual partners)questions in this section addressed; recent sexual activity in
last 30 days preceding the survey, type of sexual relationship (monogamous or polygamous),
condom use, gender of sexual partner and type of sexual practice. Section 5 addressed issues
of status disclosure. Questions were directed at number of spouse/sexual partner who were
aware of the respondents' HIV status. It also determine number of other persons HIV status
had been disclosed and the effects of such disclosure. Data was collected at baseline, 2
months and 6 months.
Questionnaires were manually validated for errors and data analyzed using SPSS (Statistical
Package for Social Sciences) version 22. All data with interval and ratio scale were
explored using graphical methods (histogram with normal distribution curve and whisker box
plot) to exam for normality. Parametric statistical test were used for normally distributed
data and non parametric equivalent used were normality assumption was violated. For
descriptive statistics measures of central tendency and dispersion were used for continuous
data. Percentages were used to describe categorical data. The median and interquartile
ranges (IQR) were used when the assumption of normality was violated.
Inferential statistics was used to determine homogeneity of respondent's socio-demographic
variable between intervention group 1, intervention group 2 and control group. Data
transformation was performed on data which were not normally distributed. Data
transformation performed on not normally distributed condom use scores with both log10 and
square root transformation was unsuccessful. One way ANOVA was used to compare mean
differences of scores of log HIV knowledge, log attitudes scores towards HIV/AIDS and HIV
status disclosure scores among the two intervention groups and the control group at
baseline, 2 months and at 6 months. Kruskal Wallis ANOVA was used to compare median condom
use scores among the 3 study groups at baseline, 2 months and 6 months. Spearman's
correlation coefficient was used to investigate relationships between HIV knowledge,
attitudes towards HIV and sexual behaviors (condom use, sex with unsteady partners and
status disclosure).
McNemar's test was used to asses treatment effects of the intervention on sound knowledge,
categorical scores of attitude and categorical sexual behavior practices related to HIV in
the present study. It was carried out for changes at 2 months and 6 months.
Mixed design ANOVA was employed to determine the main effects of age, gender, group, time
and group - time interaction effects for mean log scores of HIV knowledge, log attitude
scores towards HIV/AIDS and log HIV status disclosure scores of the 3 study groups.
Friedman's repeated measure ANOVA was used to look at main effects of group, time and group
and time interaction effects of the median condom use scores of the 3 study groups. A
partial eta square (ἠ2) as a measure of effect size representing the variance in proportions
of the dependent variable that can be explained by the independent variable was applied to
both mixed design ANOVA and Friedman's repeated measures ANOVA. The interpretation of the
strength of eta squared values followed guidelines by Cohen, 1988: small effect (0.01),
moderate effect (0.06) and large effect (0.14).
All results of log transformed data considered underlying data transformation during result
interpretation. The confidence interval was set at 95% for mean estimations. The level of
significance; alpha (α) was set at 0.05. A p value of less than 0.05 pertains to the
decision rule. The decision rule used was to reject the null hypothesis when p was less than
0.05.
;
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |